The local facility housing the Electro-Acoustic Transducer used in this study is Medsonix, located at 2626 S. Rainbow Blvd. #109, Las Vegas, NV 89146. The transducer mentioned in this study is the Cassone Transducer. This device is responsible for the Patented Therapy used to validate Mr. Cassones' discovery and to prove his Theory with the assistance of this UNLV Study.

Mr. Cassone sought the UNLV research staff to validate his claims because they provide an objective and non-biased outside independent, Institutional Review Board (IRB) approved study.

Figure 1
This is the room used in the UNLV Research study showing the Cassone Transducer that produces Medsonix Therapy System (MTS).

Conclusion The two pilot studies conclusively demonstrates the valid use of MTS effecting Peripheral Vascular Disease and Osteoarthritis. The widespread applications for just these two alone are incredible for people suffering around the world.

Mr. Cassone is very pleased with the results of these studies and is looking forward to further research the Medsonix Therapy System (MTS) on other disease entities in the near future with UNLV.

UNLV STUDY ON PERIPHERAL VASCULAR DISEASE
(File size is 193KB)

UNLV STUDY ON OSTEOARTHRITIS
(Word Document)